16-22814741-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006043.2(HS3ST2):āc.131T>Cā(p.Leu44Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000352 in 1,608,654 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006043.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HS3ST2 | NM_006043.2 | c.131T>C | p.Leu44Pro | missense_variant | 1/2 | ENST00000261374.4 | NP_006034.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HS3ST2 | ENST00000261374.4 | c.131T>C | p.Leu44Pro | missense_variant | 1/2 | 1 | NM_006043.2 | ENSP00000261374.3 | ||
HS3ST2 | ENST00000473392.1 | n.131T>C | non_coding_transcript_exon_variant | 1/4 | 5 | ENSP00000454505.1 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152136Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000318 AC: 72AN: 226112Hom.: 1 AF XY: 0.000344 AC XY: 43AN XY: 125008
GnomAD4 exome AF: 0.000359 AC: 523AN: 1456406Hom.: 0 Cov.: 30 AF XY: 0.000329 AC XY: 238AN XY: 724322
GnomAD4 genome AF: 0.000289 AC: 44AN: 152248Hom.: 0 Cov.: 33 AF XY: 0.000255 AC XY: 19AN XY: 74450
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.131T>C (p.L44P) alteration is located in exon 1 (coding exon 1) of the HS3ST2 gene. This alteration results from a T to C substitution at nucleotide position 131, causing the leucine (L) at amino acid position 44 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at